News

Alpharma expects the collaboration to significantly accelerate the expansion of its global generic product pipeline in line with company strategy. Ten products with global brand sales exceeding $20

Results from a pivotal phase II clinical trial initiated by Insmed have shown that SomatoKine, a once daily insulin-like growth factor I replacement therapy, can help children with

The single-masked phase I/II clinical study of the investigational drug Lucentis (ranibizumab) demonstrated an ability to maintain vision in patients with wet age-related macular degeneration (AMD) when used

The priority review status means the company could have a decision in only six months time, rather than the 10 months wait usually applied to such decisions. This

The company believes that this is the first time a direct antiviral drug has reached this stage of clinical testing for this patient population. More than 170 treatment

The British pharmaceutical company sought to restrict supplies of its patented medicines to third-party distributors, requesting quotas to be imposed to prevent traders purchasing their medicines in lower-cost

The new program, known as ePedigree, comes as drug industry analysts estimate that nearly 10% of drugs worldwide are counterfeit. The World Health Organization has also reported that

The patent covers methods for the treatment of breast cancer by the administration of long-acting analogues of the peptide hormone oxytocin. The patent contains a total of 11

The cream will be administered using Transport’s drug-delivery system. The herpes product delivers acyclovir, an approved treatment for cold sores, directly to impacted skin at concentrations up to